Option Care Health, Inc.(OPCH) Stock Research - Grey Stern Research

Option Care Health, Inc. (OPCH) Stock Analysis

$24.12 (1.34%)

OPCH Financial Performance


Use the table below to view Option Care Health, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $24.12 -
52 Week Low $21.39 -
52 Week High $34.63 -
Market Cap $4.1 Billion 4/11
Gross Margin 20% 9/11
Profit Margin 4% 7/11
EBITDA margin 8% 8/11
Q3 - 2024 Revenue $1.3 Billion 4/11
Q3 - 2024 Earnings $53.9 Million 6/11
Q3 - 2024 Free Cash Flow $150.7 Million 2/11
Trailing 4 Quarters Revenue $4.8 Billion 4/11
Trailing 4 Quarters Earnings $208.9 Million 6/11
Quarterly Earnings Growth -4% 10/11
Annual Earnings Growth -48% 10/11
Quarterly Revenue Growth 17% 2/11
Annual Revenue Growth 11% 3/11
Cash On Hand $483.0 Million 2/11
Short Term Debt $6.5 Million 10/11
Long Term Debt $1.1 Billion 6/11

Option Care Health, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Option Care Health, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 19.65 6/11
PS 0.86 9/11
PB 2.88 4/11
PC 8.50 11/11
Liabilities to Equity 1.40 5/11
ROA 0.06 3/11
ROE 0.15 2/11
Current Ratio 1.71 7/11
Quick Ratio 0.24 4/11
Long Term Debt to Equity 0.77 5/11
Debt to Equity 0.78 5/11
Burn Rate -60.20 11/11
Cash to Cap 0.12 1/11
CCR 2.80 3/11
EV to EBITDA 46.81 6/11
EV to Revenue 0.99 10/11

Company Details

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

CEO: Mr. John C. Rademacher

Website: https://www.optioncarehealth.com

Address: 3000 Lakeside Dr Ste 300N Bannockburn, ILLINOIS

Exchange: NASDAQ Global Select

Industry: Medical Care Facilities

Option Care Health, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Option Care Health, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Universal Health Services, Inc. UHS $11.8 Billion
Acadia Healthcare Company, Inc. ACHC $3.9 Billion
Surgery Partners, Inc. SGRY $3.0 Billion
Select Medical Holdings Corporation SEM $2.7 Billion
Encompass Health Corporation EHC $10.3 Billion
Amedisys, Inc. AMED $3.0 Billion
Addus HomeCare Corporation ADUS $2.2 Billion
The Ensign Group, Inc. ENSG $8.3 Billion
The Pennant Group, Inc. PNTG $1.1 Billion
InnovAge Holding Corp. INNV $663.7 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
OPCH Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 1.3 Billion $53.9 Million
Q2 2024 $ 1.2 Billion $53.0 Million
Q1 2024 $ 1.1 Billion $44.8 Million
Q4 2023 $ 1.1 Billion $57.2 Million
Q3 2023 $ 1.1 Billion $56.3 Million
Q2 2023 $ 1.1 Billion $114.4 Million
Q1 2023 $ 1.0 Billion $39.2 Million
Q4 2022 $ 1.0 Billion $47.5 Million

View All

OPCH Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $483.0 Million $3.4 Billion $1.1 Billion $1.4 Billion
Q2 2024 $376.9 Million $3.3 Billion $1.1 Billion $1.4 Billion
Q1 2024 $219.5 Million $3.2 Billion $1.2 Billion $1.4 Billion
Q4 2023 $343.8 Million $3.2 Billion $1.2 Billion $1.4 Billion
Q3 2023 $386.5 Million $3.2 Billion $1.1 Billion $1.4 Billion
Q2 2023 $441.2 Million $3.3 Billion $1.1 Billion $1.5 Billion
Q1 2023 $297.8 Million $3.1 Billion $1.1 Billion $1.4 Billion
Q4 2022 $294.2 Million $3.1 Billion $1.1 Billion $1.4 Billion

View All

OPCH Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 $150.7 Million -$9.7 Million $106.2 Million
Q2 2024 $0 $0 $0
Q1 2024 -$74.6 Million -$5.8 Million -$124.3 Million
Q4 2023 $73.0 Million $22.0 Million -$42.6 Million
Q3 2023 $52.6 Million -$8.4 Million -$54.7 Million
Q2 2023 $161.7 Million -$7.8 Million $143.4 Million
Q1 2023 $84.0 Million -$5.8 Million $3.6 Million
Q4 2022 $25.2 Million -$18.2 Million $38.7 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions